Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes.
Räkel
A
A
Renier
G
G
Roussin
A
A
Buithieu
J
J
Mamputu
J-C
JC
Serri
O
O
D000328:Adult; D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004311:Double-Blind Method; D004730:Endothelium, Vascular / Q000187:drug effects; D005260:Female; D005907:Gliclazide / Q000627:therapeutic use*; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007249:Inflammation / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D007004:Hypoglycemic Agents; D005907:Gliclazide; D005905:Glyburide